Zhejiang AngLiKang Pharmaceutical CO.,LTD.

SZSE:002940 Stock Report

Market Cap: CN¥3.4b

Zhejiang AngLiKang PharmaceuticalLTD Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Guo Zheng

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.3yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure5.8yrs

Recent management updates

Recent updates


CEO

Guo Zheng (50 yo)

1.3yrs

Tenure


Board Members

NamePositionTenureCompensationOwnership
Nan Ping Fang
Board Secretary & Chairman of the Board9.4yrsCN¥802.30kno data
Guo Zheng
GM & Director1.3yrsno datano data
Huihao Lu
Deputy General Manager & Vice Chairman9.4yrsCN¥602.70k3.67%
CN¥ 126.2m
Xiufang Zhao
Independent Director3.3yrsCN¥100.00kno data
Xiaoyun Pan
Non-Employee Supervisor9.4yrsno data0.32%
CN¥ 11.1m
Zhe Hua Wu
Non-Independent Director9.4yrsCN¥100.00kno data
Hong Yuan
Independent Director5.8yrsCN¥100.00kno data
Weimin Mo
Independent Director3.3yrsCN¥100.00kno data
Ling Li
Non-Employee Supervisor3.3yrsno datano data

5.8yrs

Average Tenure

54yo

Average Age

Experienced Board: 002940's board of directors are considered experienced (5.8 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.